Iambic Provides Business Updates and Third Quarter 2026 Financial Results
SAN DIEGO, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Iambic NASDAQ:IAM, a clinical-stage life sciences and technology company developing novel medicines using its AI-driven platform, today provided business updates and financial results for the third quarter ended September 30, 2026.“Iambic’s mission is to…